Skip to main content

Table 1 Characteristics of the study group

From: Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis

  Active LN (n = 16) Stable LN (n = 10) AAV (n = 6) IgAN (n = 9) MCD/FSGS (MCD, n = 4; FSGS, n = 1) HC (n = 8)
Age (years) 31 (23–45) 53 (31.75–61.25) 52 (45.5–59.5) 45 (35.5–57) 53 (40.5–62) 49.5 (40.5–55.5)
Female, n (%) 15 (93.75) 10 (100) 4 (66.67) 8 (88.89) 3 (60) 6 (75)
WBC count,  × 103/mL 4.43 (3.32–6.54) 4.30 (3.67–4.89) 9.98 (6.89–15.37) 8.1 (7.36–8.35) 8.02 (6.28–10.01) 5.44 (4.56–7.77)
CRP, mg/L 0.15 (0.07–1.15) 0.05 (0.03–0.16) 2.21 (0.38–10.35) 0.03 (0.01–0.15) 0.04 (0.02–0.05) 0.02 (0.01–0.05)
Serum BUN, mg/dL 14.5 (12–18.75) 15.5 (12.25–22.25) 31 (21.75–58.75) 17 (14.5–27) 14 (11.5–23.5) 15 (11–16)
UPCR, mg/mg 2.93 (0.90–5.87) 0.21 (0.09–0.36) 2.16 (1.233–2.97) 1.6 (0.90–4.62) 9.55 (3.99–16.88) 0.05 (0.04–0.11)
Serum anti-dsDNA, IU/ml 512 (267.9–849.8) 6.7 (2–155.9) N/A N/A N/A N/A
C3, mg/dL 44.5 (39.5–59.75) 69.5 (47.75–84.75) 106.5 (93.75–112.3) 99 (85–124) N/A N/A
C4, mg/dL 8 (5.5–16) 10.5 (4.5–21) 25 (12.5–30.25) 28 (20.5–32.5) N/A N/A
  1. The data are presented as the median and interquartile range (IQR) or as number (percentage)
  2. Abbreviations: LN lupus nephritis, AAV ANCA-associated vasculitis, IgAN IgA nephropathy, MCD minimal change disease, FSGS focal segmental glomerulosclerosis, HC healthy control, WBC white blood cell, CRP C-reactive protein, BUN blood urea nitrogen, UPCR urine protein to creatinine ratio, dsDNA double-stranded DNA, C3 complement component 3, C4 complement component 4